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Purpose or Objective: Proton and ion therapy require 
accurate prediction of particle ranges in tissue. In current 
clinical practice, computed tomography (CT) images are 
voxel-wise converted to ion-stopping power ratio maps using 
direct heuristic relations. The general validity of these 
approaches is, however, limited due to the different physical 
regimes of photon and ion interaction. Using a more 
sophisticated method based on dual-energy CT (DECT), which 
provides access to the physical quantities influencing photon 
attenuation, Hünemohr et al. (2014) reported an improved 
ion-range prediction for homogeneous tissue surrogates. 
Here, we present a major modification of the latter method, 
enabling a proper treatment of heterogeneities and mixtures 
on several structural levels, which represent a crucial feature 
of the realistic clinical situation. 
 
Material and Methods: We treat the stopping-power ratio as 
the product of the electron density relative to water and a 
correction factor that implicitly involves the logarithmic 
dependence on the mean excitation energy (I-value). The 
relative electron density, being an important parameter in 
both photon and ion energy loss, can be derived directly from 
DECT scans using a universal and robust method. The 
correction factor, however, has to be determined with an 
empirical method. For this purpose, we propose to use the 
information from CT images that is complementary to the 
relative electron density, i.e. the electronic photon 
absorption cross section relative to water. Using the 
attenuation sum rule and Bragg’s additivity rule, the relative 
cross sections and correction factors were calculated for 
single elements, tissue base materials like water, lipid, etc. 
and tabulated real tissues. 
 
Results: For a therapeutic beam energy of 200 MeV/u, the 
correction factor varies between 1.15 and 0.70 for single 
elements with atomic numbers between 1 and 100. Building 
up compounds from a certain number of elements, a 
maximum spread of possible values for the correction factor 
can be quoted for a given relative cross section, due to the 
mathematical structure of the variable space. In practice, 
this could be used as an uncertainty estimate for a given 
calibration. The accessible variable space is drastically 
reduced by admitting only tissue base materials such as 
water, lipids and hydroxylapatite. The space is further 
reduced by admitting only mixtures of real tissue materials. 
For human tissue, the correction factor is thus limited overall 
to a small range around one (0.96 - 1.02). 
 
Conclusion: With the definition of the correction factor in 
the stopping-power ratio prediction and its relation to the 
relative cross section, a mathematically rigorous treatment 
of tissue mixtures was made possible. Such mixtures 
influence CT imaging of patients e.g. in the form of volume 
averaging in a CT voxel. This thorough treatment of mixtures 
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Purpose or Objective: The development of a synthetic CT 
(synCT) derived from MR images is necessary to support MR-
only treatment planning. While we have previously developed 
a synCT solution for the brain, no clear quality assurance 
workflow currently exists for synCT validation. This work uses 
a novel MR-CT compatible 3D anthropomorphic skull phantom 
(Fig 1A) to evaluate the uncertainty in an MR-only workflow 
in the brain. 
 
Material and Methods: MR images of the phantom were 
acquired on a 1.0T High-Field Open MR-Simulator (Philips 
Medical Systems, Cleveland, OH). Triple echo ultra-short 
echo time combined with mDixon (UTE/Dixon), T1-FFE, T2-
TSE, and FLAIR images MR images were acquired using an 8-
channel head coil. Bone-enhanced images were generated via 
an optimal weighted combination of inverted UTE and 
water/fat maps automatically generated from mDixon. 
Images were then semi-automatically segmented using 
Gaussian mixture modeling before generating synCTs via a 
previously described region-specific, voxel-based, weighted 
summation method. SynCTs were validated by calculating the 
mean absolute error (MAE) between SynCT and CT-SIM. DRRs 
from CT-SIM and SynCT were generated of the phantom and 
geometric fidelity was assessed via bounding box and 
landmark analysis. On-board planar (MV/KV) and volumetric 
(CBCT) images were acquired of the phantom and rigid 
registration was compared between datasets across three 
linear accelerator platforms. 
 
Results: The MAE of the synCT for the skull phantom (Fig 1E) 
was 131 HU. Embedded landmarks between the phantom CT-
SIM DRRs and SynCT DRRs for both right lateral and anterior 
projections were <1 mm (1G). However, slight image 
intensity variations were observed across the DRRs in the 
synCT as compared to the CT-SIM. Bounding box analysis of 
the skull revealed that anterior-posterior DRRs were <1 mm 
different between synCT and CT-SIM while lateral DRRs had a 
slightly higher uncertainty in the anterior-posterior dimension 
(~2 mm). MV and KV planar image registrations were within 
0.7 mm for all linear accelerators. CBCT/CT-SIM and 




Conclusion: DRRs yielded comparable geometry between CT 
and synCT. Future work will involve an intensity 
normalization for synCT DRRs. Image registrations were 
within clinically acceptable ranges. Efforts are needed to 
combine geometric and dosimetric errors of the entire synCT 
pipeline; establishing QA workflows to quantify these 
uncertainties are necessary for MR-only treatment planning. 
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Purpose or Objective: Due to the spatial heterogeneity of 
tumors, the change of tumor size and the whole-tumor 
average method used in routine care do not reliably identify 
patients’ histologic response to therapy in sarcomas, thus 
compromising tumor control in the context of precision 
medicine. In this study, we investigated the utility of 
dynamic contrast-enhanced MRI (DCE-MRI) combined with the 
voxel-wise image analysis approach as an early predictive 
biomarker for efficacy of neoadjuvant chemoradiation 
therapy in sarcoma. 
 
Material and Methods: Serial DCE-MRI scans were performed 
on days before therapy (time point 1, TP1) and after 2 weeks 
of chemoradiation therapy (time point 2, TP2) in twelve 
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patients with high-risk extremity soft tissue sarcoma. A two-
tier registration was used to align the tumor VOI within each 
dynamic frame at TP1 and align the volumes at TP2 to the 
volumes at TP1. After registration, the voxel-wise transfer 
constant Ktrans within a VOI covering the whole tumor 
normalized to a reference region of normal tissue area closed 
to the tumor was calculated. The responder threshold was 
determined by linear regression via evaluating the 95% 
confidence interval [-T, T] in the residuals from the 
reference region. The difference of the voxel-wise ΔKtrans 
within the tumor between TP1 and TP2 was calculated. Three 
classes of voxels within the tumor VOI were determined: 
voxels having ΔKtrans value exceed threshold T were 
designated in red, below -T were designated in blue, and 
otherwise designated in green indicating no significant 
change. The volume fractions with respect to three sub-
volumes of the tumor VOI were computed as F+ (red voxels), 
F-(blue voxels) and F0 (green voxels). 
 
Results: The histopathology at the time of surgery confirmed 
that 3 patients were optimal responders to preoperative 
treatment (≥95% pathologic tumor necrosis percentage) and 9 
patients were sub-optimal responders (<95% necrosis 
percentage).F0, ΔKtrans and F- had significantly positive, 
positive and negative correlations with necrosis percentage 
(p < 0.05), respectively. The change of tumor size had no 






Conclusion: The results suggest that F0 and F-are more 
sensitive to early therapy response compared, which could 
provide the early prediction of treatment outcome while 
retain spatial localization of heterogeneous response to 
treatment in sarcoma. 
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Purpose or Objective: Biological behavior differs between 
histologies of non-small cell lung cancer (NSCLC). Tumour 
biology and glucose metabolism influence radiosensitivity. 
The first goal of this study is to calculate glucose metabolic 
rate constants k1 (glucose transporter (GLUT) influx), k2 
(GLUT efflux), k3 (hexokinase phosphorylation) and blood 
volume (VB) in adeno- versus squamous cell NSCLC using 
dynamic 18FDG PET. Heterogeneity of these parameters will 
be assessed within different tumour regions. This will 
improve understanding tumour biology and potentially form 
the basis for dose modifications in radiotherapy.  
Besides 18FDG PET as a tool indicating radioresistant tumour 
areas, PET may be used for tumour delineation in 
radiotherapy planning. Manual tumor delineation of stage III 
NSCLC for radiotherapy planning takes a lot of effort. The 
second objective of this study is to correlate tumour 
dimensions obtained by thresholds of standardized uptake 
value (SUV; static PET), metabolic rate of glucose (MRglu; 
dynamic PET) with pathological data. The most appropriate 
method may quicken tumour delineation for radiotherapy 
planning. 
 
Material and Methods: Patients with curatively resected 
NSCLC were included in this prospective study (n=35). 
Dynamic 18FDG-PET scans were acquired during 60 minutes. 
Patlak analyses using the data acquired between 15-60 
minutes post-injection were performed to calculate 
parametric images of MRglu. The last time frame was used as 
static PET scan. Tumour volumes were delineated using 50% 
of maximum, 40% of maximum above background and FLAB 
algorithm. Maximum SUV (SUVmax) and maximum MRglu 
(MRglu;max) were calculated. In on-going analysis, volumes 
acquired by the segmentation methods are correlated with 
pathology volumes to determine the optimal delineation 
method for NSCLC. Within the most appropriate method, 
pharmacokinetic rate constants k1, k2, k3, VB are currently 
being calculated using an irreversible two-compartment 
model.  
 
Results: Initial results showed that SUVmax was higher in 
squamous cell NSCLCs versus adenocarcinomas (median 17.8 
(9-33) versus 11.6 (6-32) respectively, p=0.002). Also the 
MRglu;max was higher in squamous cell carcinomas (median 
462.6 nanomol/min/g (266.4-1366.2) versus 301.5 (129.7-
1096.5) respectively, p=0.004).  
Static volumes were larger compared to the dynamic volumes 
(p<0.001). Applying FLAB algorithm on static PET resulted in 
the largest volumes (p<0.001).  
 
Conclusion: These preliminary data support differences in 
glucose metabolism between adeno- and squamous cell 
NSCLC. In the ongoing analyses, metabolic rates of glucose 
will be studied in more detail and will be correlated to 
survival. Furthermore, tumour volumes acquired by several 
segmentation methods will be correlated with pathology 
volumes to determine the optimal delineation method. This 
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Purpose or Objective: To investigate the predictive role of 
FDG-PET/CT image-derived parameters in patients with 
locally advanced oropharyngeal cancer undergoing IMRT, by 
